These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2546299)

  • 41. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
    Hertenstein B; Hampl W; Bunjes D; Wiesneth M; Duncker C; Koszinowski U; Heimpel H; Arnold R; Mertens T
    Bone Marrow Transplant; 1995 Mar; 15(3):387-93. PubMed ID: 7599563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients.
    Pollard RB; Arvin AM; Gamberg P; Rand KH; Gallagher JG; Merigan TC
    Am J Med; 1982 Nov; 73(5):679-87. PubMed ID: 6291387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
    Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
    Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.
    Drobyski WR; Piaskowski V; Ash RC; Casper JT; Truitt RL
    Transplantation; 1990 Oct; 50(4):625-32. PubMed ID: 1699309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.
    Valteau-Couanet D; Cavazzana-Calvo M; Le Deist F; Fromont C; Fischer A
    Transplantation; 1993 Dec; 56(6):1574-6. PubMed ID: 8279044
    [No Abstract]   [Full Text] [Related]  

  • 49. CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8- T cells repopulate at different rates after allogeneic bone marrow transplantation.
    Gratama JW; Fibbe WE; Visser JW; Kluin-Nelemans HC; Ginsel LA; Bolhuis RL
    Bone Marrow Transplant; 1989 May; 4(3):291-6. PubMed ID: 2543471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretransplant herpes virus serology and chronic graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
    Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.
    Goodrich JM; Mori M; Gleaves CA; Du Mond C; Cays M; Ebeling DF; Buhles WC; DeArmond B; Meyers JD
    N Engl J Med; 1991 Dec; 325(23):1601-7. PubMed ID: 1658652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.
    Asanuma H; Sharp M; Maecker HT; Maino VC; Arvin AM
    J Infect Dis; 2000 Mar; 181(3):859-66. PubMed ID: 10720505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.
    Winston DJ; Ho WG; Bartoni K; Du Mond C; Ebeling DF; Buhles WC; Champlin RE
    Ann Intern Med; 1993 Feb; 118(3):179-84. PubMed ID: 8380243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The serological relationship of varicella-zoster virus to other primate herpesviruses.
    Harbour DA; Caunt AE
    J Gen Virol; 1979 Nov; 45(2):469-77. PubMed ID: 232132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.
    Svane IM; Nikolajsen K; Hansen SW; Kamby C; Nielsen DL; Johnsen HE
    Bone Marrow Transplant; 2002 Apr; 29(8):659-66. PubMed ID: 12180110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.